These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10553709)

  • 1. Effect of quinolones on intestinal ecology.
    Edlund C; Nord CE
    Drugs; 1999; 58 Suppl 2():65-70. PubMed ID: 10553709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone activity against anaerobes.
    Appelbaum PC
    Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of quinolones on the human intestinal microflora.
    Nord CE
    Drugs; 1995; 49 Suppl 2():81-5. PubMed ID: 8549421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
    Edlund C; Nord CE
    Infection; 1988; 16(1):8-12. PubMed ID: 3283041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecological effect of gatifloxacin on the normal human intestinal microflora.
    Edlund C; Nord CE
    J Chemother; 1999 Feb; 11(1):50-3. PubMed ID: 10078781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates.
    Milatovic D; Schmitz FJ; Brisse S; Verhoef J; Fluit AC
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1102-7. PubMed ID: 10722524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone activity against anaerobes: microbiological aspects.
    Appelbaum PC
    Drugs; 1995; 49 Suppl 2():76-80. PubMed ID: 8549420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quinolones: historic review].
    Rothlin RP
    Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lomefloxacin on the normal oral and intestinal microflora.
    Edlund C; Brismar B; Nord CE
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):35-9. PubMed ID: 2303064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Tomioka H; Sato K; Akaki T; Kajitani H; Kawahara S; Sakatani M
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3001-4. PubMed ID: 10582897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gemifloxacin on the normal human intestinal microflora.
    Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
    J Chemother; 2001 Feb; 13(1):47-51. PubMed ID: 11233800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model.
    Gismondo MR; Drago L; Lombardi A; Fassina C; Cesana M
    Chemotherapy; 1995; 41(4):281-8. PubMed ID: 7555209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora.
    Nord CE; Gajjar DA; Grasela DM
    Clin Microbiol Infect; 2002 Apr; 8(4):229-39. PubMed ID: 12047415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity and pharmacodynamics of new quinolones.
    Dalhoff A; Schmitz FJ
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):203-21. PubMed ID: 12687416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.